Yu Shanshan, Chen Liyuan, Ye Lili, Fei Lingna, Tang Wei, Tian Yujiao, Geng Qian, Yi Xin, Xie Jiansheng
BGI-shenzhen, Shenzhen, 518083, China.
Prenatal Diagnosis Center, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, 518048, China.
PLoS One. 2014 Dec 2;9(12):e113914. doi: 10.1371/journal.pone.0113914. eCollection 2014.
Cockayne syndrome (CS) is a rare autosomal recessive disorder, the primary manifestations of which are poor growth and neurologic abnormality. Mutations of the ERCC6 and ERCC8 genes are the predominant cause of Cockayne syndrome, and the ERCC6 gene mutation is present in approximately 65% of cases. The present report describes a case of Cockayne syndrome in a Chinese family, with the patients carrying two missense mutations (c.1595A>G, p.Asp532Gly and c.1607T>G, p.Leu536Trp) in the ERCC6 gene in an apparently compound heterozygote status, especially, p.Asp532Gly has never been reported. The compound heterozygote mutation was found in three patients in the family using whole exome sequencing. The patients' father and mother carried a heterozygous allele at different locations of the ERCC6 gene, which was confirmed by Sanger DNA sequencing. The two mutations are both located in the highly conserved motif I of ATP-binding helicase and are considered "Damaging," "Probably Damaging," "Disease Causing," and "Conserved", indicating the role of DNA damage in the pathogenetic process of the disease. The results not only enrich the ERCC6 mutations database, but also indicate that whole exome sequencing will be a powerful tool for discovering the disease causing mutations in clinical diagnosis.
科凯恩综合征(CS)是一种罕见的常染色体隐性疾病,其主要表现为生长发育迟缓及神经功能异常。ERCC6和ERCC8基因的突变是科凯恩综合征的主要病因,其中约65%的病例存在ERCC6基因突变。本报告描述了一个中国家庭中的科凯恩综合征病例,患者携带两个ERCC6基因错义突变(c.1595A>G,p.Asp532Gly和c.1607T>G,p.Leu536Trp),呈明显的复合杂合子状态,尤其是p.Asp532Gly此前从未有过报道。通过全外显子组测序在该家庭的三名患者中发现了复合杂合子突变。患者的父亲和母亲在ERCC6基因的不同位置携带一个杂合等位基因,这通过桑格DNA测序得以证实。这两个突变均位于ATP结合解旋酶的高度保守基序I中,被认为具有“有害”“可能有害”“致病”及“保守”的特性,表明DNA损伤在该疾病发病过程中的作用。这些结果不仅丰富了ERCC6基因突变数据库,还表明全外显子组测序将成为临床诊断中发现致病突变的有力工具。